Insider Transactions Reported by 12 Insiders of Immix Biopharma, Inc.

Symbol
IMMX on Nasdaq
Location
Los Angeles, CA

Insiders trading volume in the past year

Immix Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ilya Rachman CEO and Chairman, Director $7,615,025 +$15,024 +0.2% 10 Dec 2025
Yekaterina Chudnovsky Director, 10%+ Owner $6,417,330 20 Jun 2025
Vladimir P. Torchilin Scientific Co-Founder $4,230,905 20 Dec 2021
Sean Senn Under 10% owner $4,205,665 14 Jul 2022
Dr. Nancy T. Chang Director $3,978,750 21 Nov 2025
Gabriel Morris CFO, Director $2,259,077 +$15,259 +0.68% 08 Dec 2025
Carey Ng Director $2,069,537 20 Jun 2025
Jason Hsu Director $1,867,140 20 Jun 2025
Helen C. Adams Director $346,012 20 Jun 2025
Magda Marquet Director $130,862 20 Jun 2025
JANE BUCHAN Director $44,460 20 Jun 2025
Graham Ross CMO & Head of Clinical Dev. 15 Dec 2021

Recent Insider Transactions by Companies or Individuals for Immix Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.